RecruitingNot ApplicableNCT07413991

Expressive Writing Program Among Young Adults With Blood Cancer

An Expressive Writing Program to Support Emotional Wellness Among Young Adults With Hematologic Malignancy


Sponsor

Blood Cancer United

Enrollment

100 participants

Start Date

Feb 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness. Participants will * Take part in an online expressive writing workshop for four weeks * Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patient with a hematologic malignancy diagnosis in treatment or after treatment is completed, who is currently between the ages of 18 and 39 (young adult), or the informal caregiver of a young adult blood cancer patient
  • Located within the U.S., Canada, or U.S. territories
  • Able to read and write in English

Exclusion Criteria2

  • Located outside of the U.S., Canada, or its territories
  • Participant is a minor aged 17 years or below

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALExpressive Writing Workshop

Group 1 will start the workshop the following week. Group 2 will wait 4 weeks before starting the workshop. There is an equal chance of being placed group 1 or group 2. You cannot choose your study group. The workshop is the same for both groups.


Locations(1)

Blood Cancer United

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07413991


Related Trials